COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN OPIOID AGENT

The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release,...

Full description

Saved in:
Bibliographic Details
Main Authors Hao ZHANG, Manshiu LEUNG, Venkat R. THALLADI, Yun MO, Shaoling LI
Format Patent
LanguageEnglish
Spanish
Published 11.01.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form. La invención provee una composición sólida del antagonista de los receptores opioides mu periféricos, axeloprán, y una forma farmacéutica combinada del antagonista de los receptores opioidos mu, sulfato de axeloprán, en una forma de liberación inmediata y un agente analgésico opioide que puede encontrarse en una forma de liberación prolongada, liberación sostenida, liberación modificada, o liberación controlada, y métodos para preparar dicha forma farmacéutica combinada.
Bibliography:Application Number: MX20170012474